User login

We offer our registered users tailored information, free online courses and exclusive content.

You have an old EXCEMED account ...

Our platform has been renewed. All users registered at any of the old websites are kindly requested to reset their password. Why is this?

... or you lost your password?

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Advances and challenges in the management of diabetes and thyroid disorders

Advances and challenges in the management of diabetes and thyroid disorders
  • Cardiometabolic
    Endocrinology and metabolism
  • Diabetes
    Thyroid disorder
Symposium by Excemed
Friday, Oct 10 - Saturday, Oct 11 2014
Sao Paulo, Brazil



Event format

Workshop session
Registration status


In the Latin-American nations type 2 Diabetes is a growing problem, mainly due to the spread of a western life-style characterized by a hypercaloric diet, sedentary behaviour, and finally obesity. Its management, including the related complications and comorbidities, is a challenge for the local healthcare systems and professionals, particularly because of the lack of standardised guidelines, limited medical services and limited public finance. Also, in many countries in this region, thyroid disorders are very common, mostly due to iodine deficiency but also to genetic factors, leading to nodular goiter and immune dysfunctions. Hypo- and hyperthyroidism, thyroid nodules and ultimately thyroid cancers are frequent challenges for local physicians and healthcare systems, requiring tailored medical intervention and standards of care using international guidelines. EXCEMED is focusing its efforts on organising a dedicated educational conference for health care professionals involved in the management of diabetes and thyroid disorders, particularly in regions at highest risk. The aims of this conference are to review the most significant achievements of research in the fields, and to share best practice for the clinical management of such diseases.

Learning objectives

After attending the live educational conference, participants will have up-to-date knowledge about the latest in research and clinical management of diabetes and thyroid disorders, and will be able to:

  • Improve the use of anti-diabetic agents in different hyperglycemic states also considering tools to ameliorate treatment adherence
  • Appraise insights into complications and comorbidities of diabetes for their better management in daily clinical practice
  • Recognise the burden of thyroid disorders from their diagnosis to different therapies
  • Apply the international standards of care for managing different conditions such as thyroid nodules, disorders with hypothyroidism during pregnancy and differentiated thyroid cancers

Accreditation details

EXCEMED ( is accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) to  provide  the  following CME  activity  for  medical  specialists.  The  EACCME  is  an institution  of  the  European  Union  of  Medical  Specialists  (UEMS), The Advances and challenges in the management of diabetes and thyroid disorders conference to be held in Sao Paulo, Brazil on 10-11 October 2014, is designated  for  a  maximum  of  9  (nine)  hours  of  European  CME  credits  (ECMEC). Each medical specialist should claim only those credits that he/she actually spent in the educational activity. EACCME® credits are recognized by the American Medical Association towards the Physician’s Recognition Award  (PRA). To convert EACCME credit to AMA PRA category 1 credit, please contact the AMA.

EXCEMED adheres to the principles of the Good CME Practice Group (gCMEp).

Additional information

This programme is endorsed by the Latin American Thyroid Society (LATS) and by the European Society of Endocrinology (ESE)

Scientific programme

Friday, 10 October 2014


Session I Managing the emergency of diabetes today

Chair:  Marcos Tambascia (Brazil)


09.00 L1: “Diabesity” in Latin-America: from predisposition to prevention

Walmir Coutinho (Brazil)

09.30 L2: Comparing international to local guidelines for diabetes management
Luiz Turatti (Brazil)

10.00 L3: Management of pre-diabetes: role of pharmacological therapy

Monica Manrique (Chile)


Session II Treating diabetes and improving the outcomes

Chair:  Marcos Tambascia (Brazil)


11.00 L4: Efficacy and safety of metformin as first-line therapy in diabetes

Marilia de Brito Gomes (Brazil)

11.30 L5Lowering glucose levels: from oral therapy to insulin therapy
Marcos Tambascia (Brazil)

12.00 L6: How to improve poor adherence to treatment in diabetes

Monica Manrique (Chile)

12.30 RT1: Managing hyperglycemia in the old and young people

Marilia de Brito Gomes (Brazil)

Marcos Tambascia (Brazil)


Session III From iodine deficit to thyroid autoimmune diseases

Chair:  Hans Graf (Brazil)


14.00 L7: Iodine deficiency and its consequences in Latin-America today 

Eduardo A. Pretell (Peru)

14.30 L8: Graves disease and its complications: etiology and therapy

Ana Luiza Maia (Brazil)

15.00 L9: Managing hypothyroidism according to international and local guidelines

Mario Vaisman (Brazil)


Session IV Interactive workshops with clinical case presentations (16.00-18.00)


W1: Gestational diabetes management: from diagnosis to medical therapy

Rosângela Réa (Brazil)

W2: Thyroid disorders in pregnancy: when to use thyroid hormone therapy

Gabriela Brenta (Argentina)


Saturday, 11 October 2014


Session V Complications and comorbidities of diabetes

Chair:  Marcos Tambascia (Brazil)


09.00 L10: Diabetic nephropathy: moving from pathogenesis to therapy

Louis Henrique Canani (Brazil)

09.30 L11: Unravelling the neglected problem of diabetic neuropathy 

Hermelinda Pedrosa (Brazil)

10.00 L12: Cardiovascular disease and diabetes: more than an association

Sergio A. Dib (Brazil)


Session VI Managing thyroid nodules and thyroid cancers

Chair:  Hans Graf (Brazil)


11.00 L13: Multinodular goiter: from hormone therapy to radioiodine therapy

Hans Graf (Brazil)

11.30 L14: Novel non-invasive treatment of benign thyroid nodules

Enrico Papini (Italy)

12.00 L15: International guidelines for managing differentiated thyroid cancers

Erivelto Volpi (Brazil)

12.30 RT2: Managing subclinical hypothyroidismChair:  Gabriela Brenta (Argentina)

Hans Graf (Brazil); Enrico Papini (Italy);  Mario Vaisman (Brazil); Erivelto Volpi (Brazil)


Hans Graf

Paranà Federal University
Paranà, Brazil

Marcos Tambascia

Faculty of Medical Science
University of Campinas
Campinas, Brazil


EXCEMED adheres to guidelines of the European Accreditation Council for Continuing Medical Education (EACCME ® ) and all other professional organizations, as applicable, which state that programmes awarding continuing education credits must be balanced, independent, objective, and scientifically rigorous. Investigative and other uses for pharmaceutical agents, medical devices, and other products  (other  than  those  uses  indicated  in  approved  product  labeling/package  insert  for  the  product)  may  be  presented  in  the programme (which may reflect clinical experience, the professional literature or other clinical sources known to the presenter). We ask all presenters to provide participants with information about relationships with pharmaceutical or medical equipment companies that may have relevance to their lectures. This policy is not intended to exclude faculty who have relationships with such companies; it is only intended to inform participants of any potential conflicts so that participants may form their own judgements, based on full disclosure of the facts. Further, all opinions and recommendations presented during the programme and all programme-related materials neither imply an endorsement nor a recommendation on the part of EXCEMED. All presentations represent solely the independent views of the presenters/authors.

The following faculty provided information regarding significant commercial relationships and/or discussions of investigational or non-EMEA/FDA approved (off-label) uses of drugs:

Gabriela Brenta Declared receipt of honoraria and consultation fees from Merck.

Marilia de Brito Gomes Declared no potential conflict of interest.

Walmir Coutinho Declared Consulting with Novo Nordisk, Germed, Abbott Nutrition, Weight Watchers International, Aché, Janssen, Pathway Genomics. He declared to in the boards of Janssen, Novo Nordisk, Aché, Abbott Nutrition, Merck Serono and Astra Zeneca.

Sergio A. Dib Declared no potential conflict of interest.

Hans Graf Declared no potential conflict of interest.

Ana Luiza Maia Declared receipt of grants from CNPq, FAPERGS, NIH, FIPE. She is consultant or advisor for AstraZeneca and Bayer and principal investigator for AstraZeneca and Exelixis.

Enrico Papini Declared receipt of grants and contracts: IBSA, Esaote-Elesta, Novartis.

Hermelinda Pedrosa Declared receipt of honoraria or consultation fees from Ely Lilly, Novartis, Merck Serono. She declared participation in a company sponsored speakers’ bureau: Sanofi Aventis.

Eduardo A. Pretell Declared no potential conflict of interest.

Rosângela Réa Declared no potential conflict of interest.

Marcos Tambascia Declared receipt of grants and research supports from MSD, NovoNordisk and receipt of honoraria or consultation fees from NovoNordisk, Sanofi, Takeda, Lilly, Boehringer-Ingelheim.  He declared participation in a company sponsored speaker’s bureau: NovoNordisk, Sanofi, Boehringer- Ingelheim, Lilly.

Luiz Turatti Declared receipt of honoraria and consultation fees from Sanofi, Astra Zeneca, Merck. Novartis, Lilly.  He declared to be member of a company advisory board, board of directors or other similar groups: Sanofi, Merck and Novartis.

Mario Vaisman Declared to be member of a company advisory board, board of directors or other similar groups: Sanofi.

Erivelto Volpi Declared no potential conflict of interest.

The following faculty have provided no information regarding significant relationship with commercial supporters and/or discussion of investigational or non-EMEA/FDA approved (off-label) uses of drugs as of 25 September 2014.

Jorge Gross

Monica Manrique